Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Mizuarai
Small-Molecule Inhibition of Wee1 Kinase by MK-1775 Selectively Sensitizes P53-Deficient Tumor Cells to DNA-damaging Agents
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
MK-1775, a Small Molecule Wee1 Inhibitor, Enhances Anti-Tumor Efficacy of Various DNA-damaging Agents, Including 5-Fluorouracil
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Depletion of ATR Selectively Sensitizes ATM-deficient Human Mammary Epithelial Cells to Ionizing Radiation and DNA-damaging Agents
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Genetic Inhibition of the Atypical Kinase Wee1 Selectively Drives Apoptosis of P53 Inactive Tumor Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Multiple Defects Sensitize P53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Selinexor Reduces the Expression of DNA Damage Repair Proteins and Sensitizes Cancer Cells to DNA Damaging Agents
Oncotarget
Oncology
Hyperactive End Joining Repair Mediates Resistance to DNA Damaging Therapy in P53-Deficient Cells
Sensitization of Cancer Cells to DNA Damaging Agents by Imidazolines
Small-Molecule Ferroptotic Agents With Potential to Selectively Target Cancer Stem Cells
Scientific Reports
Multidisciplinary
